 |
|
| Infectious Diseases |
|
| • |
Anaplasma phagocytophilium Antibodies (IgG, IgM) |
| • |
Anaplasma phagocytophilium DNA, QL, Real-Time PCR |
| • |
Atypical Pneumonia DNA Panel, Qualitative Real-Time PCR |
| • |
Babesia
microti Antibodies
(IgG, IgM) |
| • |
Babesia
microti DNA, PCR |
| • |
Bacterial Vaginosis/Vaginitis Panel |
| • |
BK Virus DNA, Real-Time PCR |
| • |
Borrelia
burgdorferi Antibody Index for CNS Infection |
| • |
Borrelia
hermsii Antibody Panel, IFA |
| • |
CD4 Lymphocyte Count and Percentage |
| • |
Chlamydia trachomatis Antibody |
| • |
Chlamydia trachomatis Culture |
| • |
Chlamydia trachomatis, DFA |
| • |
Chlamydia trachomatis, DNA Probe |
| • |
Chlamydia trachomatis
DNA, SDA |
| • |
Chlamydia trachomatis RNA, TMA |
| • |
Colorado Tick Fever Antibody, IFA |
| • |
E.
coli Shiga Toxin, EIA, Stool |
| • |
Ehrlichia
chaffeensis Antibodies (IgG, IgM) |
| • |
Ehrlichia chaffeensis
DNA, Real-Time PCR |
| • |
Ehrlichia ewingii DNA, Real-Time PCR |
| • |
Francisella tularensis
Antibody,
DA |
| • |
Helicobacter pylori Antibody |
| • |
Helicobacter pylori Antigen |
| • |
Helicobacter pylori
Culture |
| • |
Helicobacter pylori Urea Breath Test
(UBiT®′) |
| • |
Helicobacter pylori Urease |
| • |
Hepatitis A Virus Antibodies |
| • |
Hepatitis B
Viral DNA |
| • |
Hepatitis B Virus Antibodies |
| • |
Hepatitis B Virus Antigens |
| • |
Hepatitis B Virus Drug Resistance,
Genotype, and BCP/Precore Mutations |
| • |
Hepatitis C Viral RNA Genotype, LiPA |
| • |
Hepatitis C Viral RNA, Qualitative PCR |
| • |
Hepatitis C Viral RNA, Qualitative
TMA |
| • |
Hepatitis C Viral RNA, Quantitative
Real-Time PCR |
| • |
Hepatitis C Viral RNA, Quantitative TMA |
| • |
Hepatitis C Virus Antibody |
| • |
Hepatitis D Virus Antibody |
| • |
Hepatitis D Virus Antigen |
| • |
Hepatitis E Virus Antibody |
| • |
HEPTIMAX®
HCV RNA |
| • |
HIV Antibody, EIA or Western Blot |
| • |
HIV Culture |
| • |
HIV-1
Coreceptor Tropism |
| • |
HIV-1 DNA, Qualitative PCR |
| • |
HIV-1 Genotype |
| • |
HIV-1
gp41 Envelope Genotype |
| • |
HIV-1
Integrase Genotype |
| • |
HIV-1 Phenotype (PhenoSense®′)
|
| • |
HIV-1 RNA, Qualitative
TMA |
| • |
HIV-1 RNA, Quantitative
bDNA |
| • |
HIV-1 RNA, Quantitative
Real-Time PCR |
| • |
HIV-1
VirtualPhenotype™ |
| • |
HLA-B*5701
Typing |
|
• |
HPV
Genotypes 16 and 18 |
|
• |
HPV (Human Papillomavirus), High Risk DNA, Hybrid Capture II |
| • |
HSV 1/2 IgG, HerpeSelect®′
Type-specific Antibody |
| • |
HTLV-I/II Antibody, EIA with Positives Reflexed to Western Blot |
| • |
Human Ehrlichiosis DNA Panel |
| • |
Infection Control, Microbial Strain Matching |
| • |
Influenza A
and B Culture, Rapid Method |
| • |
Influenza
A H1N1 (2009) Real-Time RT-PCR |
| • |
JC Virus DNA, Real-Time PCR |
| • |
Liver Fibrosis Panel, HepaScore™ |
| • |
Lyme Disease Antibody, Total, EIA |
| • |
Lyme Disease Antibodies, Western Blot |
| • |
Lyme Disease C6 Antibodies |
| • |
Lyme Disease (B burgdorferi) Culture |
| • |
Lyme
Disease (Borrelia burgdorferi) DNA, QL, Real-Time PCR |
| • |
Lymphocyte Subset Panels |
| • |
Malaria/Babesia Examination by Giemsa Stain |
| • |
β2-Microglobulin |
| • |
Neisseria gonorrhoeae
Culture |
| • |
Neisseria gonorrhoeae, DNA
Probe |
| • |
Neisseria gonorrhoeae DNA,
SDA |
| • |
Neisseria gonorrhoeae
RNA,
TMA |
| • |
Parvovirus B19 DNA, Qualitative
Real-time PCR |
| • |
Q Fever (Coxiella burnetii) Antibodies
(IgG, IgM) |
| • |
Respiratory
Virus Panel, Qualitative Real-Time PCR |
| • |
Rickettsia Antibody Panel |
| • |
Rickettsia rickettsii DNA, Real-Time PCR |
| • |
Rocky Mountain Spotted Fever (Rickettsia rickettsii) Antibodies
(IgG, IgM) |
| • |
Shiga
Toxins, EIA |
| • |
Susceptibility, Yeast,
Comprehensive Panel |
| • |
Tick (and other Arthopods) Identification |
| • |
Tick ID with Reflex to Lyme Disease (Borrelia burgdorferi) DNA |
| • |
Trichomonas vaginalis RNA, Qualitative TMA |
| • |
West Nile Virus Antibodies (IgG, IgM) |
| • |
West Nile Virus RNA,
Qualitative Real-time PCR |
